Across the full study period, patients with multiple myeloma/amyloidosis (n = 122) were either chemo-mobilized with cyclophosphamide in addition to G-CSF or received G-CSF as the sole agent for mobilization (26.2% and 73.8%, respectively). Here, CSF3 is linked to plasma cell myeloma.